Guangdong Taiantang Pharmaceutical Co. Ltd. | Ownership
Companies that own Guangdong Taiantang Pharmaceutical Co. Ltd.
Rongtong Fund Management Co., Ltd.
8,103,792
1.17%
8,103,792
0.24%
09/30/2017
China Investment Corp. (Investment Management)
5,756,600
0.83%
0
0.01%
09/30/2017
Huatai Baoxing Fund Management Co. Ltd.
4,223,400
0.61%
4,223,400
9.78%
09/30/2017
China Great Wall Asset Management Co., Ltd. (Invt Mgmt)
4,100,090
0.59%
0
0.16%
09/30/2017
The Vanguard Group, Inc.
1,691,178
0.25%
0
0%
07/31/2018
Guotai Junan Allianz Fund Management Co., Ltd.
1,657,374
0.24%
-243,600
0.08%
12/31/2017
E Fund Management Co., Ltd.
1,101,200
0.16%
1,101,200
0.01%
12/31/2017
GF Fund Management Co., Ltd.
341,912
0.05%
37,902
0%
12/31/2017
Tian Hong Asset Management Co., Ltd.
173,600
0.03%
34,400
0.01%
12/31/2017
Western Leadbank Fund Management Co., Ltd
103,900
0.02%
69,800
0.01%
12/31/2017
| Address |
Kirin Park
Shantou Guangdong 515021
China
|
|
Employees
|
- |
| Website |
http://www.taiantang.net |
| Updated |
07/08/2019 |
| Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the development, production, and sale of chinese medicines. Its products include inside and outside chinese medicine for skin, infertility drugs, cardiovascular drugs, and drugs for children. The company was founded in 1995 and is headquartered in Shantou, China. |
